Vandetanib angiogenesis inhibitors

Zactima - vandetanib - ZD-6474 - ZD6474 - ZD 6474 - caprelsa      

pdf
pathology Benefit (demonstrated or suggested) and harm      
lung cancer (metastatic)

All results are NS for efficacy

inferior to pemetrexed in terms of ORR in De Boer, 2011

meta-analysis